CLINICAL TRIALS
A 30 day clinical trial was conducted by ABICH LABS in Italy to test the effectiveness of ONE TRUTH 818 and its active TAM-818 (Telomerase Activating Molecule) on 100 volunteers aged 36-65.The trial investigated the product's ability to reduce wrinkles and improve skin elasticity and firmness.
The trial used specialised equipment for measuring the skin's surface and elasticity, an in-vivo 3D-Scanner and a Cutometer.
Results showed that the product reduced skin roughness in the treated areas, which were crows feet and forehead, after twice daily application. The decrease was measured using 2 parameters, wrinkle depth and roughness.
x
Wrinkle depth decreased by an average of 11.07% and roughness decreased by an average of 9.63% in the crow’s feet area after 30 days. These changes were deemed statistically significant.
x
Wrinkle depth decreased by an average of 14.04% and roughness decreased by 12.53% in the forehead area after 30 days. These changes were deemed statistically significant.
x
Skin firmness improved on average 20.33% after 30 days. These changes were deemed statistically significant.
x
Elasticity increased by an average of 8.33% after 30 days. These changes were deemed statistically significant.
x
Wrinkle depth decreased by an average of 11.07% and roughness decreased by an average of 9.63% in the crow’s feet area after 30 days. These changes were deemed statistically significant.
x
Wrinkle depth decreased by an average of 14.04% and roughness decreased by 12.53% in the forehead area after 30 days. These changes were deemed statistically significant.
x
Skin firmness improved on average 20.33% after 30 days. These changes were deemed statistically significant.
x
Elasticity increased by an average of 8.33% after 30 days. These changes were deemed statistically significant.
